St. Jude Medical‘s ANS Division has received FDA and EU approvals for the EonC™, the longest lasting non-rechargeable neurostimulator of its kind.
The following product features are listed in St. Jude’s press release:
The EonC neurostimulator provides a convenient option for chronic pain patients who prefer or require the simplicity of a non-rechargeable medical device. Featuring the greatest battery capacity of any primary cell neurostimulator, the EonC may maximize the time between device replacement procedures…
Proprietary technology (called NeuroDynamix(TM)) which helps deliver stimulation with greater efficiency Advanced programming capability which allows patients to adjust therapy strength in up to eight pain areas simultaneously and independently Constant current circuitry which automatically adjusts power output to deliver consistent therapy over time High power and high pulse frequencies which enable clinicians to adjust the therapy to accommodate individual patient needs
EonC is the only 16-contact, constant current, non-rechargeable system for SCS therapy
Press release: St. Jude Medical Receives U.S. and European Approvals of EonC, the First Extended-Life Primary Cell Neurostimulator for the Treatment of Chronic Pain
Product page: Primary Cell IPG Systems